Chemokine and Cytokine Profiles in Patients with Hand Osteoarthritis

• Published in: Biomolecules (Basel, Switzerland) Vol. 11; no. 1; p. 4
• Main Authors: Baloun, Jiří, Kropáčková, Tereza, Hulejová, Hana, Tomčík, Michal, Růžičková, Olga, Šléglová, Olga, Gatterová, Jindřiška, Vencovský, Jiří, Pavelka, Karel, Šenolt, Ladislav
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI 22.12.2020; MDPI AG
• Subjects: chemokines; cytokines; erosive disease; hand osteoarthritis; cytokines; hand osteoarthritis; chemokines; erosive disease
• ISSN: 2218-273X; 2218-273X
• DOI: 10.3390/biom11010004

The development of hand osteoarthritis (HOA) and its progression into the erosive subset are unclear, but inflammation is suspected to be the main source. To verify the involvement of inflammation in HOA pathogenesis, we evaluate serum inflammatory mediators and their association with HOA-related clinical features in patients. 153 participants (50 non-erosive HOA patients, 54 erosive HOA patients, and 49 healthy control subjects) were included in this study. All patients underwent clinical examination, which included assessment of tender and swollen small hand joints, ultrasound (US) examination, and self-reported measures (e.g., AUSCAN or algofunctional indexes). Serum inflammatory mediators were quantified using human cytokine 27-plex immunoassay. We employed linear modelling, correlation analysis, and resampling statistics to evaluate the association of these mediators to HOA. We identified increased levels of nine inflammatory mediators (e.g., eotaxin, monocyte chemoattractant protein 1, interleukin-8, and tumour necrosis factor) in HOA patients compared to healthy controls. Increased mediators correlated with ultrasound findings as well as with clinically tender and swollen joint counts in patients with erosive HOA. However, none of the mediators distinguished between erosive and non-erosive HOA subtypes. Our findings support the hypothesis on the involvement of inflammation in HOA.